Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Contemporary Clinical Trials Communications
|
May 14, 2023
Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial
Pishoy Gouda, Robert Kay, Arjun Gupta, et al.
CJEM
|
September 29, 2018
Sex-specific, high-sensitivity cardiac troponin T cut-off concentrations for ruling out acute myocardial infarction with a single measurement
Andrew McRae, Michelle Graham, Tasnima Abedin, et al.
The Canadian Journal of Cardiology
|
November 21, 2016
Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery
Emmanuelle Duceppe, Joel Parlow, Paul MacDonald, et al.
The Canadian Journal of Cardiology
|
July 4, 2017
Comparative Evaluation of 2-Hour Rapid Diagnostic Algorithms for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T
Andrew D McRae, Grant Innes, Michelle Graham, et al.
Plant Physiology
|
March 18, 2006
Recruitment of novel calcium-binding proteins for root nodule symbiosis in Medicago truncatula
Junqi Liu, Susan S Miller, Michelle Graham, et al.
International Journal of Cardiology
|
August 1, 2021
Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions
Andrija Matetic, Mohamed Mohamed, Robert J H Miller, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
May 26, 2017
Undetectable Concentrations of a Food and Drug Administration-approved High-sensitivity Cardiac Troponin T Assay to Rule Out Acute Myocardial Infarction at Emergency Department Arrival
Andrew D McRae, Grant Innes, Michelle Graham, et al.
International Journal of Clinical Practice
|
September 13, 2021
Trends in cardiovascular mortality of cancer patients in the US over two decades 1999-2019
Ofer Kobo, Sophia Khattak, Juan Lopez-Mattei, et al.
Frontiers in Oncology
|
February 17, 2025
Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors
Toshio Shimizu, John Powderly, Albiruni Abdul Razak, et al.
Frontiers in Oncology
|
November 13, 2024
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors
Toshio Shimizu, John Powderly, Albiruni Abdul Razak, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Contemporary Clinical Trials Communications
|
May 14, 2023
Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial
Pishoy Gouda, Robert Kay, Arjun Gupta, et al.
CJEM
|
September 29, 2018
Sex-specific, high-sensitivity cardiac troponin T cut-off concentrations for ruling out acute myocardial infarction with a single measurement
Andrew McRae, Michelle Graham, Tasnima Abedin, et al.
The Canadian Journal of Cardiology
|
November 21, 2016
Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery
Emmanuelle Duceppe, Joel Parlow, Paul MacDonald, et al.
The Canadian Journal of Cardiology
|
July 4, 2017
Comparative Evaluation of 2-Hour Rapid Diagnostic Algorithms for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T
Andrew D McRae, Grant Innes, Michelle Graham, et al.
Plant Physiology
|
March 18, 2006
Recruitment of novel calcium-binding proteins for root nodule symbiosis in Medicago truncatula
Junqi Liu, Susan S Miller, Michelle Graham, et al.
International Journal of Cardiology
|
August 1, 2021
Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions
Andrija Matetic, Mohamed Mohamed, Robert J H Miller, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
May 26, 2017
Undetectable Concentrations of a Food and Drug Administration-approved High-sensitivity Cardiac Troponin T Assay to Rule Out Acute Myocardial Infarction at Emergency Department Arrival
Andrew D McRae, Grant Innes, Michelle Graham, et al.
International Journal of Clinical Practice
|
September 13, 2021
Trends in cardiovascular mortality of cancer patients in the US over two decades 1999-2019
Ofer Kobo, Sophia Khattak, Juan Lopez-Mattei, et al.
Frontiers in Oncology
|
February 17, 2025
Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors
Toshio Shimizu, John Powderly, Albiruni Abdul Razak, et al.
Frontiers in Oncology
|
November 13, 2024
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors
Toshio Shimizu, John Powderly, Albiruni Abdul Razak, et al.
Page
of 6